Published in Ann Surg on August 01, 1989
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
The Problem of Portal Hypertension in Relation to the Hepatosplenopathies. Ann Surg (1945) 13.38
Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg (1967) 5.62
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
A randomized, controlled trial of the distal splenorenal shunt. Ann Surg (1978) 2.15
Sclerotherapy of bleeding oesophageal varices by means of endoscopy. Endoscopy (1978) 2.10
Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology (1985) 1.80
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg (1986) 1.62
The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg (1985) 1.50
Comparison of distal and proximal splenorenal shunts: a randomized prospective trial. Ann Surg (1981) 1.27
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology (1985) 1.23
Selective variceal decompression after splenectomy or splenic vein thrombosis. With a note on splenopancreatic disconnection. Ann Surg (1984) 1.10
Portal pseudoperfusion: an angiographic illusion. Ann Surg (1979) 1.02
Primary pulmonary hypertension: an unusual case associated with extrahepatic portal hypertension. Hepatology (1983) 0.93
GASTROESOPHAGEAL DECONGESTION AND SPLENECTOMY. A METHOD OF PREVENTION AND TREATMENT OF BLEEDING FROM ESOPHAGEAL VARICES ASSOCIATED WITH BILHARZIAL HEPATIC FIBROSIS: PRELIMINARY REPORT. J Int Coll Surg (1964) 0.85
An improved method of estimating the portal venous fraction of total hepatic blood flow from computerized radionuclide angiography. Radiology (1983) 0.84
The distal splenorenal shunt. Arch Surg (1984) 0.84
Immediate endoscopic sclerosis of bleeding esophageal varices. A prospective evaluation over five years. Surg Endosc (1988) 0.81
[Quantitative liver perfusion scintigraphy. Experimental and clinical investigation in normal and pathologic liver perfusion (author's transl)]. Langenbecks Arch Chir (1980) 0.81
[Sonographic determination of liver volume. Problems, methods and practical significance of liver volume measurements (author's transl)]. Rofo (1979) 0.78
Ten years of selective shunts for hemorrhagic portal hypertension. Surgery (1988) 0.78
[A new therapeutic concept for the selection of liver cirrhotics with recurrent bleeding esophageal varices for selective shunt]. Chirurg (1979) 0.77
[Portal thrombosis after selective portasystemic shunts]. Rev Invest Clin (1988) 0.77
Selective splenocaval shunt: an alternate choice. Surgery (1978) 0.77
[Liver perfusion scintigraphy: method, normal values and results of observations on the course of patients with esophageal varices]. Nuklearmedizin (1985) 0.77
Selective shunts for portal hypertension: current role of a 21-year experience. Liver Transpl Surg (1997) 1.45
Long-term evolution of asymptomatic cholelithiasis diagnosed during abdominal operations for variceal bleeding in patients with cirrhosis. Am J Surg (1994) 1.40
Frequency, significance and therapy of the Mallory-Weiss syndrome in patients with portal hypertension. Hepatology (1990) 1.39
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. Br J Surg (1991) 1.27
Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology (1999) 1.17
Prophylactic sclerotherapy for esophageal varices in high-risk cirrhotic patients selected by endoscopic and hemodynamic criteria: a randomized, single-center controlled trial. Endoscopy (1994) 1.16
Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure. J Hepatol (1999) 1.11
Surgical management of extrahepatic portal hypertension and variceal bleeding. World J Surg (1994) 1.03
The Sugiura procedure for patients with hemorrhagic portal hypertension secondary to extrahepatic portal vein thrombosis. Surg Gynecol Obstet (1991) 0.99
Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg (1998) 0.97
Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J Hepatol (1996) 0.96
The evolution of portal hypertension surgery: lessons from 1000 operations and 50 Years' experience. Arch Surg (2000) 0.86
Evidence for Ca(2+)-permeable AMPA receptors in the olfactory bulb. Am J Physiol Cell Physiol (2005) 0.84
Is there an indication for prophylactic endoscopic paravariceal injection sclerotherapy in patients with liver cirrhosis and portal hypertension? Endoscopy (1986) 0.84
Elective treatment of bleeding varices with the Sugiura operation over 10 years. Am J Surg (1992) 0.83
[Immediate sclerotherapy of acute hemorrhaging esophageal varices in emergency endoscopy. A prospective study]. Dtsch Med Wochenschr (1986) 0.82
Is splenectomy necessary in devascularization procedures for treatment of bleeding portal hypertension? Arch Surg (1998) 0.82
Immediate endoscopic sclerosis of bleeding esophageal varices. A prospective evaluation over five years. Surg Endosc (1988) 0.81
Survival and quality of life after portal blood flow preserving procedures in patients with portal hypertension and liver cirrhosis. Am J Surg (1994) 0.81
Sugiura procedure outside Japan. The Mexican experience. Am J Surg (1986) 0.81
Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Br J Surg (1995) 0.80
Evaluation and management of the persistent/recurrent varicocele. Urology (2011) 0.79
Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis. Dig Dis Sci (1988) 0.78
Ten years of selective shunts for hemorrhagic portal hypertension. Surgery (1988) 0.78
Role of the distal splenorenal shunt in management of variceal bleeding in Latin America. Am J Surg (1990) 0.78
Hepatic chemoinfusion of 5-FU in metastasis of gastrointestinal cancer and advanced primary hepatocellular carcinoma. Eur J Surg Oncol (1992) 0.77
A comparative clinical study of idiopathic portal hypertension, extrahepatic portal vein thrombosis, and cirrhosis. J Clin Gastroenterol (1994) 0.77
[Evaluation of 20 years of experience and quality of life in patients surgically treated for liver cystic disease]. Rev Gastroenterol Mex (2002) 0.77
[The effect of alcohol on portal vein hemodynamics in nutritional-toxic liver cirrhosis]. Dtsch Med Wochenschr (1993) 0.76
Surgery in Mexico. Arch Surg (2000) 0.76
[Diagnosis of chronic hepatitis]. Dtsch Med Wochenschr (1998) 0.75
Injection sclerotherapy in patients with extrahepatic portal venous obstruction. Ann Surg (1995) 0.75
[Umbilical and inguinal hernioplasty in cirrhotic patients]. Rev Invest Clin (1995) 0.75
Colorectal variceal bleeding in patients with extrahepatic portal vein thrombosis and idiopathic portal hypertension. J Clin Gastroenterol (1992) 0.75
[Bilateral renal angiomyolipomatosis]. Fortschr Geb Rontgenstr Nuklearmed (1974) 0.75
[Primary cancer of the liver]. Rev Gastroenterol Mex (1998) 0.75
Treatment of chronic active hepatitis--present state. Hepatogastroenterology (1984) 0.75
Partial hepatectomy for Caroli's syndrome. Report of two patients with long-term follow-up. Hepatogastroenterology (1991) 0.75
[Can patients with liver diseases participate in sports? Standardized walking and swimming tests in 220 patients with acute and chronic liver diseases]. Fortschr Med (1987) 0.75
Conservative and semi-invasive modalities for treating bleeding esophageal varices. Hepatogastroenterology (1990) 0.75
[Postoperative handling in biliodigestive derivation by iatrogenic bile duct injury]. Rev Gastroenterol Mex (2008) 0.75
[Laparoscopic cholecystectomy. First year experience at the Salvador Zubirán National Institute of Nutrition]. Rev Invest Clin (1993) 0.75
Comparison of outcomes and complications for open and laparoscopic cholecystectomy in Mexico. J Laparoendosc Surg (1995) 0.75
[Chronic destructive non-suppurating cholangitis]. Fortschr Med (1982) 0.75
Analysis of a prospective series of 100 mesocaval interposition shunts for bleeding portal hypertension. Hepatogastroenterology (1990) 0.75
[A safe, extended right-side hemihepatectomy using anatomic preparation, controlled hypotension and compression of the hepatoduodenal ligament. Technic, early and late results]. Chirurg (1984) 0.75
Selective splenocaval shunt for bleeding portal hypertension: fifteen-year evaluation period. Surgery (1993) 0.75
Surgery in elderly patients in Mexico. Portal hypertension surgery as an example. Arch Surg (1997) 0.75
Prognosis after meso-caval interposition shunt. Experience of eighty-six consecutive cases over a period of ten years. Int Surg (1988) 0.75
[Incidence and significance of bleeding from gastric varices in liver cirrhosis ,its diagnostic and therapeutic relevance]. Schweiz Rundsch Med Prax (1984) 0.75
[Science vs. technology vs. marketing: the case of video-assisted endoscopic surgery]. Rev Gastroenterol Mex (1994) 0.75
Investigation of the portal perfusion index after low diameter mesocaval interposition and distal splenorenal shunt--a prospective study. Surg Endosc (1991) 0.75
[Homage to Dr. Héctor Orozco Zepeda]. Rev Gastroenterol Mex (1999) 0.75
[Undifferentiated (embryonal) sarcoma of the liver. Report of a case]. Rev Invest Clin (1992) 0.75
[Causes and diagnostic criteria of hepatic coma--an analysis of 560 cases]. Leber Magen Darm (1983) 0.75
100 meso-caval interposition-shunts for recurrent variceal hemorrhage in portal hypertension. A prospective study. Rev Invest Clin (1990) 0.75
[Prognosis of chronic active hepatitis. Retrospective 10 year study of 144 patients]. Fortschr Med (1985) 0.75
[Therapeutic and preventive sclerosing of esophageal varices]. Fortschr Med (1986) 0.75
The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. I. Clinical and general biochemical findings. Hepatogastroenterology (1986) 0.75
[The liver transplant]. Rev Gastroenterol Mex (1993) 0.75
Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients. Transplant Proc (1996) 0.75
[Cholecystectomy in liver cirrhosis with portal hypertension--limited surgical indications and increased surgical risk?]. Chirurg (1986) 0.75
Prospective evaluation and long-term results of mesocaval interposition shunts. Acta Chir Scand (1987) 0.75
[Physical endurance of patients with chronic hepatitis. The standardized treadmill test of 95 patients with liver biopsy verified disease]. Med Klin (Munich) (1987) 0.75
[Idiopathic portal hypertension]. Rev Invest Clin (1991) 0.75
[Primary lipoma of the liver]. Rev Gastroenterol Mex (2001) 0.75
[A comparative study of complications after vagotomy-pyloroplasty using Sugiura-Futagawa procedure and surgery of acid peptic disease]. Rev Gastroenterol Mex (1997) 0.75
Primary biliary cirrhosis: ammonia metabolism and liver function. Dig Dis Sci (1986) 0.75
[Fibrin glue injection--a hemostatic technic after laparoscopic liver biopsy]. Dtsch Med Wochenschr (1989) 0.75
[Elective-selective Warren splenorenal shunt operation. Prognosis of liver function and esophageal varices hemorrhage after repeat sclerotherapy in liver cirrhosis]. Chirurg (1991) 0.75
[Is intrahepatic cholangiojejunostomy in liver hilus-localized malignant occlusive jaundice a better alternative to endoscopic transhepatic drainage?]. Chirurg (1987) 0.75
[Congenital synostosis of the lunate and triquetral carpal bones (os lunatotriquetrum)]. Handchirurgie (1980) 0.75
New technique for veno-venous bypass in a canine liver transplant model. Transplant Proc (1992) 0.75
[Open cholecystectomy in cirrhotic patients. Experience at the Salvador Zubirán National Institute of Nutrition]. Rev Gastroenterol Mex (1997) 0.75
Long-term endoscopic injection sclerotherapy of bleeding esophageal varices. A prospective analysis of results by endoscopy, manometry and 24-h pH-monitoring. Surg Endosc (1989) 0.75